Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to
bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or
activities that put stress on the tendons.
Increasing cases of tendinitis, introduction of new treatments and therapies, increasing
awareness, and increasing healthcare expenditure are major driving forces for the market.
Up to 50% of all sports injury in the United States comprise overuse tendinitis of the hand
and wrist.
Global Tendinitis Treatment Market is expected to grow at the CAGR of ~3.8% during the
forecast period and is estimated to reach USD 426.4 million by 2023.
Segments:
Global Tendinitis Treatment Market has been segmented on the basis of condition which
comprises of tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, jumper's
knee, and others.
On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and
others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI)
scans, and others.
On the basis of treatments, the market has been segmented into medications, therapy,
surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids,
Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold
therapy, physical therapy, occupational therapy, and others.
On the basis of end user, it is segmented into hospitals & clinics, medical research centers,
academic institutes, and others.
Key players for global Tendinitis treatment market:
Almatica Pharma, Inc. (US), AstraZeneca (US), Bayer (Germany), Boehringer Ingelheim
Pharmaceuticals, Inc. (US), Merck & Co., Inc (US), Pfizer (US), and others.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/3876 .
Regional analysis of global Tendinitis treatment market:
Considering the global scenario of the market, America is the top contributor in this market.
The Americas mainly includes North America and South America. Due to developed
healthcare infrastructure and increasing R&D funding, US is dominating country in this
region. Europe is second largest market for tendinitis treatment. Due to innovative product
development and rapid adoption of new treatments, Germany is dominating this market.
Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly changing
healthcare sector, increasing awareness, and rising healthcare expenditure. Middle East and
Africa is expected to have limited growth while Middle Eastern countries are expected to
dominate this market during the forecast period.